159 related articles for article (PubMed ID: 24282087)
1. Steroid receptor co-activator-3 promotes osteosarcoma progression through up-regulation of FoxM1.
Geng S; Wang X; Xu X; Zhang H; Ma Y; Zhang Y; Li B; Bi Z; Yang C
Tumour Biol; 2014 Apr; 35(4):3087-94. PubMed ID: 24282087
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.
Duan N; Hu X; Yang X; Cheng H; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10250-60. PubMed ID: 26617733
[TBL] [Abstract][Full Text] [Related]
3. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis.
Li Z; Li H; Chen J; Luo H; Zeng J; Yao Y; Duan M
Int J Biochem Cell Biol; 2020 Sep; 126():105797. PubMed ID: 32668328
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
7. Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma.
Chang H; Dong T; Ma X; Zhang T; Chen Z; Yang Z; Zhang Y
Biochem Biophys Res Commun; 2015 Aug; 464(1):45-50. PubMed ID: 26032498
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
9. MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1.
Tao J; Cong H; Wang H; Zhang D; Liu C; Chu H; Qing Q; Wang K
Biochem Biophys Res Commun; 2018 Sep; 503(2):1092-1097. PubMed ID: 29936179
[TBL] [Abstract][Full Text] [Related]
10. Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma.
Li Y; Zhang T; Zhang Y; Zhao X; Wang W
Cancer Sci; 2018 Oct; 109(10):3093-3104. PubMed ID: 30099814
[TBL] [Abstract][Full Text] [Related]
11. TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma.
Liang J; Xing D; Li Z; Shen J; Zhao H; Li S
Mol Med Rep; 2016 Jun; 13(6):5200-6. PubMed ID: 27121462
[TBL] [Abstract][Full Text] [Related]
12. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
13. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
14. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
16. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression.
Nandi I; Smith HW; Sanguin-Gendreau V; Ji L; Pacis A; Papavasiliou V; Zuo D; Nam S; Attalla SS; Kim SH; Lusson S; Kuasne H; Fortier AM; Savage P; Martinez Ramirez C; Park M; Katzenellenbogen JA; Katzenellenbogen BS; Muller WJ
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36795481
[TBL] [Abstract][Full Text] [Related]
17. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
[TBL] [Abstract][Full Text] [Related]
19. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
[TBL] [Abstract][Full Text] [Related]
20. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
Wang W; Guo Z; Yu H; Fan L
J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
